AstraZeneca’s China boss, one of the country’s most high-profile pharmaceutical executives, is under investigation by Beijing authorities, as a crackdown on the sector intensifies.
The British drugmaker said on Wednesday that its China president Leon Wang was “co-operating with an ongoing investigation”. The statement did not clarify the nature of the probe.
The pharmaceutical chief has been crucial to AstraZeneca’s fortunes in China, where it generated $5.9bn in revenues last year, making it the largest overseas drugmaker by sales in the country. AstraZeneca shares fell 4 per cent in afternoon trading in London on Wednesday.
您已閱讀19%（631字），剩余81%（2651字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。